|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T85.42XA |
Displacement of breast prosthesis and implant, initial encounter
|
T8542XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
| 48.41%
|
29.46%
|
12.57%
|
5.44%
|
1.13%
|
1.69%
|
0.75%
|
0.38%
|
0.19%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.42XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
194
|
366
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
182
|
722
|
|
J2405
|
ONDANSETRON HCL INJECTION |
168
|
754
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
150
|
5,275
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
141
|
949
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
135
|
343
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
106
|
216
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
103
|
693
|
|
J1170
|
HYDROMORPHONE INJECTION |
96
|
150
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
86
|
139
|
|
J7120
|
RINGERS LACTATE INFUSION |
81
|
120
|
|
19342
|
INSJ/RPLCMT BRST IMPLT SEP D |
74
|
74
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
70
|
98
|
|
19380
|
REVJ RECONSTRUCTED BREAST |
68
|
68
|
|
88300
|
SURGICAL PATH GROSS |
62
|
76
|
|
J2001
|
LIDOCAINE INJECTION |
52
|
690
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
51
|
222
|
|
15777
|
ACELLULAR DERM MATRIX IMPLT |
47
|
47
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
47
|
57
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
38
|
54
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.42XA related to the following DRG Codes:
600-601
|
